kras mutation and glutathion glynac mutation: from undruggable to druggable in cancer Targeting mutated GTPase KRAS in
Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges PMC Acetyl CoA metabolism in cancer PMC Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



